BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ox.ac.uk//NONSGML oxford.event//EN
X-WR-TIMEZONE:Europe/London
BEGIN:VTIMEZONE
TZID:Europe/London
X-LIC-LOCATION:Europe/London
BEGIN:DAYLIGHT
DTSTART:19700329T010000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3
TZNAME:BST
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
END:DAYLIGHT
BEGIN:STANDARD
DTSTART:19701025T020000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10
TZNAME:GMT
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
SUMMARY:Global innovation in mental health
DTSTART;TZID=Europe/London:20260521T170000
DTEND;TZID=Europe/London:20260521T183000
DTSTAMP:20260517T060655Z
UID:a729d83f-224a-f111-bec7-7c1e52046306
CREATED:20260507T143719Z
DESCRIPTION:Mental disorders are among the top 10 leading causes of health
  loss worldwide: in 2023\, 15% of the world’s population experienced men
 tal disorders and 17% of the total years lived with disability in the worl
 d were due to mental disorders. Anxiety\, depression and psychosis rank as
  the most burdensome disorders across all age groups and locations\, and 7
 1% of this global burden could be avoided if all people with these disorde
 rs accessed optimal treatment.\n\nJoin Andrea Cipriani\, Professor of Psyc
 hiatry\, University of Oxford\, in conversation with Alan Stein\, Director
  of the Children and Climate Initiative\, Blavatnik School of Government\,
  as he discusses how living evidence synthesis is transforming mental heal
 th research and accelerating the development of more effective treatments.
 \n\nIn mental health science\, there has been frustratingly slow process i
 n developing new treatments\, as well as in predicting which treatments wi
 ll work for whom and in what contexts. To intervene early and deliver opti
 mal care to patients\, we need to understand the underlying mechanisms of 
 mental health conditions\, develop safe and effective interventions that t
 arget these mechanisms\, and improve our capabilities in timely diagnosis 
 and reliable prediction of symptom trajectories.\n\nBetter synthesis of ex
 isting evidence is one way to reduce waste and improve efficiency in resea
 rch towards these ends. The Global Alliance for Living Evidence on aNxiety
 \, depressiOn and pSychosis (GALENOS) is funded by Wellcome and tackles th
 e challenges of mental health science research by cataloguing and evaluati
 ng the full spectrum of relevant scientific research including both human 
 and preclinical studies in living systematic reviews. GALENOS also allows 
 the mental health community—including patients\, carers\, clinicians\, r
 esearchers\, funders and policy makers—to better identify the research q
 uestions that most urgently need to be answered and accelerate discovery s
 cience into effective new interventions.\n\nIllustrative examples from GAL
 ENOS and its new strategic collaboration with the Blavatnik School of Gove
 rnance will be presented.
LAST-MODIFIED:20260507T143759Z
LOCATION:Blavatnik School of Government\, Blavatnik School of Government R
 adcliffe Observatory Quarter  Oxford Oxfordshire OX2 6GG United Kingdom
SPEAKER:Alan Stein (Blavatnik School of Government)\, Andrea Cipriani (Uni
 versity of Oxford)
END:VEVENT
END:VCALENDAR
